Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Non-Current Assets: 2021-2025

Historic Non-Current Assets for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Sep 2025 value amounting to $236.8 million.

  • Kiniksa Pharmaceuticals International's Non-Current Assets fell 2.95% to $236.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $236.8 million, marking a year-over-year decrease of 2.95%. This contributed to the annual value of $248.8 million for FY2024, which is 0.51% down from last year.
  • According to the latest figures from Q3 2025, Kiniksa Pharmaceuticals International's Non-Current Assets is $236.8 million, which was down 1.68% from $240.8 million recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's 5-year Non-Current Assets high stood at $250.0 million for Q4 2023, and its period low was $30.6 million during Q2 2022.
  • Its 3-year average for Non-Current Assets is $239.2 million, with a median of $241.4 million in 2024.
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Non-Current Assets dropped by 10.93% in 2022 and then spiked by 677.77% in 2023.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's Non-Current Assets (Quarterly) stood at $36.4 million in 2021, then surged by 495.84% to $216.6 million in 2022, then rose by 15.43% to $250.0 million in 2023, then dropped by 0.51% to $248.8 million in 2024, then fell by 2.95% to $236.8 million in 2025.
  • Its Non-Current Assets was $236.8 million in Q3 2025, compared to $240.8 million in Q2 2025 and $243.4 million in Q1 2025.